EXETER PHARMA CONSULTANCY, LTD. - LONDON
Company Profile | Company Filings |
Overview
EXETER PHARMA CONSULTANCY, LTD. is a Private Limited Company from LONDON UNITED KINGDOM and has the status: Active.
EXETER PHARMA CONSULTANCY, LTD. was incorporated 9 years ago on 02/01/2015 and has the registered number: 09371058. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 26/04/2024.
EXETER PHARMA CONSULTANCY, LTD. was incorporated 9 years ago on 02/01/2015 and has the registered number: 09371058. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 26/04/2024.
EXETER PHARMA CONSULTANCY, LTD. - LONDON
This company is listed in the following categories:
70229 - Management consultancy activities other than financial management
70229 - Management consultancy activities other than financial management
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
28 / 1 | 31/01/2022 | 26/04/2024 |
Registered Office
LOWER THIRD FLOOR EVELYN SUITE, QUANTUM HOUSE
LONDON
EC4A 3EB
UNITED KINGDOM
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
02/01/2023 | 16/01/2024 |
Map
UNITED KINGDOM
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MS LESLIE SANDBERG ORNE | Nov 1979 | American | Director | 2024-02-14 | CURRENT |
MS REBECCA MCNAMARA | Sep 1973 | American | Director | 2024-02-14 | CURRENT |
MONICA ANN MARTIN DE BUSTAMANTE | Oct 1986 | American,Spanish | Director | 2015-01-02 | CURRENT |
MONICA ANN MARTIN DE BUSTAMANTE | Secretary | 2016-01-12 | CURRENT | ||
CYRUS AZHAR CHOWDHURY | Nov 1979 | American | Director | 2015-01-02 UNTIL 2021-07-11 | RESIGNED |
TEMPLE SECRETARIAL LIMITED | Corporate Secretary | 2015-01-02 UNTIL 2016-01-12 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Exeter Pharma Consultancy, Llc | 2016-04-06 | London | Ownership of shares 75 to 100 percent |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
TRINITY_LIFE_SCIENCES_UK_ - Accounts | 2024-04-30 | 31-01-2023 | £414,696 Cash £-814,407 equity |
EXETER_PHARMA_CONSULTANCY - Accounts | 2023-05-12 | 31-01-2022 | £201,008 Cash £-466,059 equity |
EXETER_PHARMA_CONSULTANCY - Accounts | 2021-10-30 | 31-01-2021 | £46,666 Cash £10,030 equity |
EXETER_PHARMA_CONSULTANCY - Accounts | 2021-01-27 | 31-01-2020 | £43,274 Cash £77,945 equity |